SITAGLYN 100 Tablet 10’s

Description

SITAGLYN 100 Tablet is an oral antidiabetic medication commonly prescribed for the management of type 2 diabetes mellitus. it belongs to a class of drugs known as dipeptidyl peptidase-4 (dpp-4) inhibitors, which help regulate blood glucose levels in a glucose-dependent manner. unlike some older diabetes medications that stimulate insulin release regardless of blood sugar levels, SITAGLYN 100 Tablet works by enhancing the body’s natural ability to control glucose, thereby reducing the risk of excessively low blood sugar (hypoglycemia). it is often used as part of a comprehensive diabetes management plan that includes diet modification, regular physical activity, and sometimes other medications.

the mechanism of action of SITAGLYN 100 Tablet revolves around its ability to inhibit the dpp-4 enzyme. this enzyme normally breaks down incretin hormones such as glucagon-like peptide-1 (glp-1) and glucose-dependent insulinotropic polypeptide (gip). these hormones are released after eating and play a critical role in increasing insulin secretion and decreasing glucagon levels in response to elevated blood glucose. by inhibiting dpp-4, SITAGLYN 100 Tablet prolongs the activity of incretin hormones, leading to improved insulin release from the pancreas and reduced glucose production by the liver. this dual effect contributes to better glycemic control.

SITAGLYN 100 Tablet is primarily intended for adults diagnosed with type 2 diabetes mellitus, especially those who are unable to achieve adequate blood sugar control through lifestyle changes alone. it may be prescribed as a monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin. it is not suitable for individuals with type 1 diabetes or for the treatment of diabetic ketoacidosis. due to its favorable safety profile and low risk of hypoglycemia when used alone, it is often preferred for patients who require a well-tolerated long-term treatment option.

another advantage of SITAGLYN 100 Tablet is its weight-neutral effect, meaning it does not typically cause weight gain, which is a common concern with some diabetes medications. this makes it particularly useful for patients who are overweight or obese. additionally, its once-daily dosing and minimal gastrointestinal side effects contribute to better patient adherence and overall treatment satisfaction. however, as with any medication, it should be used under the supervision of a healthcare provider who can tailor therapy based on individual patient needs.

ingredients

• SITAGLYN 100 Tablet (as SITAGLYN 100 Tablet phosphate): the primary active ingredient responsible for inhibiting the dpp-4 enzyme, thereby increasing incretin hormone levels, improving insulin secretion, and reducing hepatic glucose production.
• microcrystalline cellulose: an inactive ingredient used as a filler to provide structure and stability to the tablet formulation.
• magnesium stearate: a lubricant that helps in the manufacturing process by preventing ingredients from sticking to equipment.
• croscarmellose sodium: a disintegrant that aids in the rapid breakdown of the tablet in the digestive system for efficient absorption.
• film coating agents: substances used to coat the tablet for improved appearance, stability, and ease of swallowing.

key uses

• type 2 diabetes mellitus: helps lower blood glucose levels by improving insulin secretion and reducing glucagon production.
• combination therapy: used alongside other medications like metformin or insulin to enhance glycemic control when single therapy is insufficient.
• improving postprandial glucose: particularly effective in reducing blood sugar spikes after meals.
• long-term glycemic management: supports sustained control of blood glucose levels to reduce the risk of diabetes-related complications.

how to use

SITAGLYN 100 Tablet is typically taken orally once daily, with or without food, as directed by a healthcare professional. it should be swallowed whole with water and should not be crushed or chewed unless advised otherwise. consistency is important, so it is recommended to take the medication at the same time each day to maintain stable blood levels. patients should continue to follow a balanced diet and exercise regimen alongside the medication for optimal results.

regular monitoring of blood glucose levels is essential while using SITAGLYN 100 Tablet to ensure effective control and to detect any potential fluctuations. dose adjustments may be required in patients with kidney impairment, as the drug is primarily eliminated through the kidneys. patients should never alter their dosage or discontinue the medication without consulting their healthcare provider, as this may lead to uncontrolled blood sugar levels.

safety information

• warnings: SITAGLYN 100 Tablet may increase the risk of pancreatitis, a potentially serious condition characterized by severe abdominal pain. patients should seek immediate medical attention if they experience persistent stomach pain, nausea, or vomiting.
• side effects: common side effects include headache, upper respiratory tract infections, and mild gastrointestinal discomfort. serious side effects, although rare, may include severe joint pain, allergic reactions, and pancreatitis.
• precautions: patients with a history of pancreatitis, kidney disease, or hypersensitivity to SITAGLYN 100 Tablet should use caution. kidney function should be assessed before starting treatment and monitored periodically.
• pregnancy/breastfeeding: the safety of SITAGLYN 100 Tablet during pregnancy and breastfeeding is not well established. it should only be used if clearly needed and prescribed by a healthcare provider.
• interactions: SITAGLYN 100 Tablet may interact with other medications such as insulin or sulfonylureas, increasing the risk of hypoglycemia. alcohol consumption may also affect blood sugar levels and should be limited.

additional information

• storage: store SITAGLYN 100 Tablet tablets at room temperature, away from moisture, heat, and direct sunlight. keep out of reach of children.
• missed dose: if a dose is missed, it should be taken as soon as remembered. if it is close to the time for the next dose, skip the missed dose and continue with the regular schedule. do not double the dose.
• overdose: overdose may lead to severe hypoglycemia or other complications. immediate medical attention is required if an overdose is suspected.
• habit forming: SITAGLYN 100 Tablet is not habit-forming and does not cause dependence.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.